ESTABLISHMENT LABS HOLDINGS INC.

Listed Company

ESTACIK 0001688757NasdaqLarge AcceleratedOrthopedic, Prosthetic & Surgical Appliances & SuppliesD8CRFY ends Dec 31

Period

FY 2025

Revenue

$211.08M

Net Income

$-51.06M

Total Assets

$357.17M

Equity

$23.55M

Shares Out

29.43M

Op. Cash Flow

$-50.89M

ESTA$89.47+101.94% · past yearDBEQ Basic

Daily closing prices

Business

Establishment Labs Holdings Inc. is a global medical technology company focused on breast aesthetics and reconstruction through its proprietary Motiva Implants product line. The company manufactures silicone gel-filled breast implants with proprietary technologies including SmoothSilk surface, ProgressiveGel formulations, RFID traceability, and minimally invasive surgical systems like Mia Femtech and Preservé. Products are sold in over 100 countries through exclusive distributors and direct sales forces in key markets including the United States, Brazil, Europe, and other regions.

Summary from 10-K filed 2026-02-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	211	166	165	162	127
Cost of revenue	65	57	58	55	41
Gross profit	146	110	107	107	85
Sales, general and administrative	165	140	146	126	92
Research and development	20	20	26	20	18
Total operating expenses	185	160	172	146	111
Loss from operations	−39	−50	−65	−40	−25
Interest income	423,000	1	1	87,000	23,000
Interest expense	−25	−21	−15	−12	—
Other income (expense), net	6	−15	816,000	−3	−6
Loss before income taxes	−58	−85	−79	−73	−40
Benefit (provision) for income taxes	7	32,000	81,000	−2	−1
Net loss	−51	−85	−79	−75	−41
Basic net loss per share (in dollars per share)	−1.72	−3	−3.07	−3.08	−1.72
Diluted net loss per share (in dollars per share)	−1.72	−3	−3.07	−3.08	−1.72
Weighted average outstanding shares used for basic net loss per share (in shares)	30	28	26	24	24
Weighted average outstanding shares used for diluted net loss per share (in shares)	30	28	26	24	24

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	76	90	40	66	—
Accounts receivable, net of allowance for credit losses of $6,835 and $3,088 at December 31, 2025 and 2024, respectively	77	65	47	35	24
Inventory, net	86	79	79	37	28
Prepaid expenses and other current assets	11	9	8	12	7
Total current assets	250	243	175	150	113
Property and equipment, net	76	78	77	51	19
Goodwill	1	1	465,000	465,000	465,000
Intangible assets, net of accumulated amortization	10	12	8	5	4
Right-of-use operating lease assets, net	4	6	3	4	2
Other non-current assets	16	7	5	1	558,000
Total assets	357	347	269	211	140
Accounts payable	43	45	42	20	14
Accrued liabilities	19	17	14	17	16
Other liabilities, short-term	20	7	2	2	1
Total current liabilities	82	68	57	39	32
Note payable, Oaktree, net of debt discount and issuance costs	248	220	189	175	—
Operating lease liabilities, non-current	3	4	3	3	2
Other liabilities, long-term	1	2	2	2	2
Total liabilities	334	294	250	219	89
Commitments and contingencies (Note 16)	—	—	—	—	—
Common shares zero par value, unlimited amount of shares authorized at December 31, 2025 and 2024; 29,713,024 and 29,195,439 shares issued at December 31, 2025 and 2024, respectively; 29,304,954 and 28,787,369 shares outstanding at December 31, 2025 and 2024, respectively	433	420	316	224	220
Additional paid-in-capital	88	77	64	50	37
Treasury shares, at cost, 408,070 shares held at December 31, 2025 and 2024	−3	−3	−3	−3	−3
Accumulated deficit	−496	−445	−360	−282	−206
Accumulated other comprehensive income	1	3	2	3	4
Total shareholders equity	24	53	18	−8	51
Total liabilities and shareholders equity	357	347	269	211	140

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	10	7	4	4	—
Provision for credit losses	3	2	1	111,000	200,000
Provision for inventory obsolescence	3	2	1	2	338,000
Change in reserve for PP&E impairment	0	0	−341,000	341,000	0
Provision for deferred income taxes	−9	−2	−4	—	—
Share-based compensation	11	14	14	13	10
Loss from disposal of property and equipment	153,000	163,000	280,000	229,000	170,000
Unrealized foreign currency (gain)/loss, net	−10	5	−4	2	4
Amortization of right-to-use asset	911,000	743,000	717,000	469,000	406,000
Non-cash loss on contract termination	543,000	6	0	0	—
Stock compensation in lieu of cash fees	403,000	964,000	495,000	0	0
Interest capitalized for construction in progress	0	−555,000	−4	−2	0
Non-cash interest expense and amortization of debt discount	3	6	13	8	2
Accounts receivable	−11	−26	−12	−12	−7
Inventory	−7	−471,000	−42	−11	−8
Prepaid expenses and other current assets	2	86,000	3	−4	−2
Other assets	454,000	−483,000	318,000	−750,000	90,000
Accounts payable	−2	7	19	4	5
Accrued liabilities	2	4	−2	3	5
Operating lease liabilities	−887,000	−646,000	−689,000	−378,000	−408,000
Other liabilities	4	1	97,000	117,000	143,000
Net cash used in operating activities	−51	−59	−89	−52	−28
Purchases of property and equipment	−6	−6	−8	−3	−2
Cash used in business acquisitions, net of cash acquired	−307,000	−50,000	0	0	—
Cost incurred for intangible assets	−672,000	−7	−1	−1	−1
Capital expenditures on construction in progress	0	−2	−15	−30	−3
Net cash used in investing activities	−7	−16	−25	−35	−7
Issuance of common stock, net of underwriters discount and issuance costs	0	99	85	0	0
Borrowings under Oaktree credit agreement, net of debt discount and issuance costs	25	24	0	168	0
Borrowings on short term notes payable	10	0	0	—	—
Repayments of short term notes payable for insurance premium financing	−1	0	0	—	—
Proceeds from stock option exercises	8	2	2	4	5
Tax payments related to shares withheld upon vesting of restricted stock	−637,000	−510,000	−484,000	−4,000	−356,000
Net cash provided by financing activities	40	126	86	100	4
Effect of exchange rate changes on cash and cash equivalents	3	−1	513,000	−358,000	−465,000
Net (decrease)/increase in cash and cash equivalents	−15	50	−26	13	−31
Cash paid for interest	21	10	6	5	7
Cash paid for income taxes	420,000	2	2	2	652,000
Unpaid balance for property and equipment	144,000	240,000	3	1	22,000
Unpaid balance for intangible assets	581,000	592,000	3	0	0
Equity consideration in an asset acquisition	0	0	250,000	0	0
Equity consideration issued in a business acquisition	4	1	0	0	—
Contingent consideration payable related to a business acquisition	4	973,000	0	0	—
Consideration payable related to a business acquisition	315,000	3	0	0	—
Cashless option exercises	0	0	5	0	2
Cashless warrant exercises	0	600,000	0	0	—
Cash payable to settle contract termination	0	214,000	0	0	—
Liability to issue shares to settle contract termination	0	1	0	0	—
Borrowings of short term notes payable for insurance premium financing	3	0	0	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is ESTABLISHMENT LABS HOLDINGS INC.'s CIK number?

ESTABLISHMENT LABS HOLDINGS INC.'s SEC CIK number is 0001688757 (1688757). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find ESTABLISHMENT LABS HOLDINGS INC.'s SEC filings?

All of ESTABLISHMENT LABS HOLDINGS INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did ESTABLISHMENT LABS HOLDINGS INC. last report earnings?

ESTABLISHMENT LABS HOLDINGS INC. (ESTA) most recently filed an earnings 8-K with the SEC on May 6, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001688757-26-000038). This is ESTABLISHMENT LABS HOLDINGS INC.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is ESTABLISHMENT LABS HOLDINGS INC.'s most recent earnings 8-K?

ESTABLISHMENT LABS HOLDINGS INC.'s latest earnings 8-K (Item 2.02) was filed May 6, 2026 under accession 0001688757-26-000038. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View ESTABLISHMENT LABS HOLDINGS INC.'s latest earnings 8-K →
Look up any company's CIK number →